Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Allison Welsh"'
Autor:
Oliver C. Frenzel, Mark Strand, Allison Welsh, Heidi Eukel, Elizabeth Skoy, Jayme Steig, Amy Werremeyer
Publikováno v:
Journal of Pharmacy Technology. 39:3-9
Background: Pharmacy practice continues to expand in scope, and technology platforms to assist with meeting the standards for documentation of billable services are needed. The ONE Program (Opioid and Naloxone Education) is an initiative centered on
Autor:
Joshua M. Lang, Scott M. Berry, David J. Beebe, Philip J. Stephens, Scott M. Dehm, Lakeesha Carmichael, David J. Guckenberger, Benjamin K. Gibbs, Jacob Tokar, Stephanie M. Thiede, Erika Heninger, Sacha Horn, Zachery Chalmers, Benjamin P. Casavant, Allison Welsh, Lindsay N. Strotman, Jamie M. Sperger
This supplementary file contains additional Matierials and Methods detailing the VERSA process. Figure S1. Longitudinal analysis of capture efficiency of Epcam antibody. Figure S2. Multi-parametric analysis of gene expression, genomic profiling and A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca5e0fa3cd3dead5194942679be1ba2
https://doi.org/10.1158/1078-0432.22465053
https://doi.org/10.1158/1078-0432.22465053
Autor:
Joshua M. Lang, Scott M. Berry, David J. Beebe, Philip J. Stephens, Scott M. Dehm, Lakeesha Carmichael, David J. Guckenberger, Benjamin K. Gibbs, Jacob Tokar, Stephanie M. Thiede, Erika Heninger, Sacha Horn, Zachery Chalmers, Benjamin P. Casavant, Allison Welsh, Lindsay N. Strotman, Jamie M. Sperger
Purpose: There is a critical clinical need for new predictive and pharmacodynamic biomarkers that evaluate pathway activity in patients treated with targeted therapies. A microscale platform known as VERSA (versatile exclusion-based rare sample analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e034db025c6058e5996b73db3a7aab3c
https://doi.org/10.1158/1078-0432.c.6525912
https://doi.org/10.1158/1078-0432.c.6525912
Autor:
Vincent A. Miller, Siraj M. Ali, Fadi Braiteh, Craig Devoe, Philip J. Stephens, Jeffrey S. Ross, Jason K. Sicklick, Razelle Kurzrock, Joseph Chao, Richard D. Carvajal, Rodolfo Bordoni, Bryan Leyland-Jones, Lauren Young, Allison Welsh, Brady Forcier, Jon H. Chung, Samuel J. Klempner, Dean Pavlick, Alexa B. Schrock
Supplemental Figure 1. Distribution of EGFR extracellular domain (ECD) mutations in ctDNA samples from patients with CRC. Supplemental Figure 2. Response to crizotinib in a patient with small bowel adenocarcinoma and GOPC-ROS1 fusion. Supplemental Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170255c4ff650fe8b42505905ee89975
https://doi.org/10.1158/1078-0432.22470560.v1
https://doi.org/10.1158/1078-0432.22470560.v1
Autor:
Vincent A. Miller, Siraj M. Ali, Fadi Braiteh, Craig Devoe, Philip J. Stephens, Jeffrey S. Ross, Jason K. Sicklick, Razelle Kurzrock, Joseph Chao, Richard D. Carvajal, Rodolfo Bordoni, Bryan Leyland-Jones, Lauren Young, Allison Welsh, Brady Forcier, Jon H. Chung, Samuel J. Klempner, Dean Pavlick, Alexa B. Schrock
Purpose: Genomic profiling of tumor biopsies from advanced gastrointestinal and anal cancers is increasingly used to inform treatment. In some cases, tissue biopsy can be prohibitive, and we sought to investigate whether analysis of blood-derived cir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f585f9528efe486d07e5f1a6116054
https://doi.org/10.1158/1078-0432.c.6527618.v1
https://doi.org/10.1158/1078-0432.c.6527618.v1
Autor:
Anand Pathak, Anand Kolatkar, Amir Ali Talasaz, Julia A. Beaver, Daniel Edelstein, Matthew Ryder, Jerry S.H. Lee, Peter Kuhn, Lea M. Salvatore, Justin Johnson, Seema Singh Bhan, Allison Welsh, David A. Eberhard, James H Godsey, Howard I. Scher, Melanie Hullings, Carolyn Compton, James W. Hicks, Matthew Smalley, Robert L. Grossman, Jonathan W. Simons, Jake Vinson, Gideon M. Blumenthal, David Reese, Sean E. Hanlon, Walt Wells, Rebecca Levine, Phillip G. Febbo, Wendy Royalty, Lauren C. Leiman, Bryan Moy, Hsian-Rong Tseng, Ryan Dittamore, Daniel H. Hovelson, Daniel P. Miller, Anne-Marie Martin, Donald J Johann, Andrew E. Schade, J. Carl Barrett, Hakan Sakul, Carissa Moore, Stella Somiari, Kelli Bramlett, Paul J. Beresford, Andrew Gruen, Reena Philip, John K. Simmons, Angela Silvestro, Jean-Francois Martini, Muneesh Tewari
Publikováno v:
Clinical Pharmacology and Therapeutics
Autor:
Deepa S. Subramaniam, Ben C. Creelan, Farah Khalil, M. Usman Ahmad, Allison Welsh, Nazaneen N. Grant, Metin Ozdemirli, Frank J. Kaszuba
Publikováno v:
The Oncologist. 24:829-835
Background Juvenile-onset recurrent respiratory papillomatosis (JO-RRP) is a human papilloma virus-mediated progressive benign neoplasm that affects children and young adults. Primary management consists of regular surgical debulking to maintain airw
Autor:
Brady Forcier, Alexa B. Schrock, Siraj M. Ali, Jon Chung, Allison Welsh, Jeffrey S. Ross, Philip J. Stephens, Dean Pavlick, Vincent A. Miller, Alice T. Shaw, Eric H. Bernicker, Sai-Hong Ignatius Ou, Tianhong Li, Benjamin C. Creelan, Ibiayi Dagogo-Jack
Publikováno v:
Journal of Thoracic Oncology. 14:255-264
Introduction Genomic profiling informs selection of matched targeted therapies as part of routine clinical care in NSCLC. Tissue biopsy is the criterion standard; however, genomic profiling of blood-derived circulating tumor DNA (ctDNA) has emerged a
Autor:
Lauren Young, Samuel J. Klempner, Jeffrey S. Ross, Bryan Leyland-Jones, Fadi Braiteh, Razelle Kurzrock, Siraj M. Ali, Brady Forcier, Alexa B. Schrock, Vincent A. Miller, Jason K. Sicklick, Allison Welsh, Craig Devoe, Rodolfo Bordoni, Dean Pavlick, Richard D. Carvajal, Jon Chung, Joseph Chao, Philip J. Stephens
Publikováno v:
Clinical Cancer Research. 24:1881-1890
Purpose: Genomic profiling of tumor biopsies from advanced gastrointestinal and anal cancers is increasingly used to inform treatment. In some cases, tissue biopsy can be prohibitive, and we sought to investigate whether analysis of blood-derived cir
Publikováno v:
Genes, Chromosomes and Cancer. 57:430-433
Tumor genome sequencing has become an invaluable resource in determining targets for new therapies. In this report, we describe the case of a patient with metastatic urothelial carcinoma with sarcomatoid features. Sarcomatoid differentiation is a rar